Article Details

Obicetrapib improves lipid profiles for patients with genetic high cholesterol or ASCVD

Retrieved on: 2025-05-13 13:41:48

Tags for this article:

Click the tags to see associated articles and topics

Obicetrapib improves lipid profiles for patients with genetic high cholesterol or ASCVD. View article details on hiswai:

Summary

The article discusses Obicetrapib, a CETP inhibitor, and its efficacy in lowering LDL cholesterol in patients with familial hypercholesterolemia or atherosclerosis. Diabetes is highlighted as a notable adverse event; this relates to managing lipid disorders, statin use, and cardiovascular risks.

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo